A total of 72,01,070 people have recuperated from COVID-19 so far, pushing the national recovery rate to 90.62 per cent while the case fatality rate stands at 1.50 per cent.
The number of total active COVID-19 cases stood at 6,53,717.
With this, the total coronavirus cases in the country have risen to 1,06,67,736 including 1,84,182 active cases and 1,03,30,084 total discharges. However, the total death toll in the country due to the infection mounted to 1,53,470 including the new deaths.
The ICMR said people having symptoms like fever, cough, sore throat and runny nose and residing in hotspots or cluster areas and in evacuee centres will now be tested for coronavirus infection.
For six days in a row the active cases of COVID-19 remained below 9 lakh.
For the fifth day in a row, the active cases of COVID-19 remained below 9 lakh.
The total recoveries have surged to 58,27,704 while there are 9,02,425 active cases of coronavirus infection in the country.
According to the Indian Council of Medical Research, 7,31,10,041 samples have been tested up to September 28 for COVID-19. Out of these 11,42,811 samples were tested on Monday.
The coronavirus caseload surged to 56,46,010, while the death toll climbed to 90,020 with 1,085 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
There are 12 sites across India, including private and public hospitals, conducting Phase 1 and 2 human clinical trials for Bharat Biotech's Covaxin. Based on an earlier letter by the Indian Council of Medical Research (ICMR) to the 12 sites, volunteer recruitments for the clinical trials were to begin by July 7. At least three sites are yet to kick-start the process.
There are 9,75,861 active cases of the coronavirus infection in the country which comprises 17.54 per cent of the total caseload, the data stated.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
The COVID-19 active caseload remained below two lakh for the 14th consecutive day.
The number of people who have recuperated from the disease surged to 1,31,08,582, while the case fatality rate has further dropped to 1.18 per cent, the data stated.
Here is an explainer on the functioning of the seven-year-old body.
Training his guns on Modi, he said, '(The) PM is silent. He has surrendered and is refusing to fight the pandemic.'
The Union health ministry has also directed airport and port health officers to be vigilant, they said.
The government is taking the cutoff of about 100 days if reinfection occurs.
Registering a steady increase, the active cases have increased to 34,47,133 comprising 17 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 81.91 per cent, the data updated at 8 am showed.
With 17,51,555 people defeating the disease, the recovery rate has surged to 71.17 per cent.
The death toll due to COVID-19 climbed to 47,033 with 942 people succumbing to the disease in the last 24 hours, health ministry data updated at 8 am showed.
The death toll has increased to 2,34,083 with 3,915 fatalities being reported in a span of 24 hours, the data updated at 8 am showed.
The number of people who have recuperated from the disease surged to 1,45,56,209 while the case fatality rate has further dropped to 1.12 per cent, the data stated.
According to the Federation of Resident Doctors Association, during the indefinite strike, all outpatient departments, operation theatres, and ward duties will be shut, but emergency services will continue to operate as usual, ensuring that urgent patient care remains unaffected.
Registering a steady increase for the 34th day in a row, the number of active cases rose to 12,64,698, or 9.24 per cent of the total infections.
Coronavirus cases in India hit a record daily high since the the outbreak of the pandemic with 1,03,558 new infections pushing the nationwide COVID-19 tally to 1,25,89,067, according to the Union health ministry data.
The death toll increased to 1,62,927 with 459 daily new fatalities, the highest in around 116 days.
'All the big production houses are making superhero films, so I thought I should make one too. So I have made a genuine superhero film,' Vivek Agnihotri says about his new film, The Vaccine War.
The number of active cases remained below 5 lakh for the fifth consecutive day.
The ICMR-National Institute of Virology has been regularly undertaking studies to understand the protective efficacy of COVID-19 vaccines against emerging variants.
The COVID-19 active caseload remained below 2 lakh.
One of those infected with the virus was a nine-year-old boy.
A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the government informed Parliament on Friday.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28 and crossed 70 lakh on October 11.
The recovery rate was recorded at 76.28 per cent, while the COVID-19 case fatality rate has further declined to 1.82 per cent.
As many as 67,95,103 people have recuperated from the disease so far pushing the national recovery rate to 88.81 per cent while the case fatality rate due COVID-19 has dropped to 1.51 per cent.
India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health Ministry said on Thursday.
India has crossed the 3-crore mark in Covid-19 tests and its tests per million stand at 21,769. Where does that place India vis--vis other nations?
The total coronavirus cases mounted to 49,30,236, while the death toll climbed to 80,776 with 1,054 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
There are 9,73,175 active cases of COVID-19 in the country which comprises 20.47 per cent of the total caseload, the data stated.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances